SCHEMBL4726770

SCHEMBL4726770

Cc1ccc(Cn2ccc(C(N)=O)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
CACNA1G O43497 2/20 0.50
CACNA1H O95180 2/20 0.50
CACNA1I Q9P0X4 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
HDAC1 Q13547 1/20 0.49
TSHR P16473 5/20 0.48
LMNA P02545 3/20 0.48
ALDH1A1 P00352 3/20 0.48
ATM Q13315 1/20 0.48
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
USP2 O75604 1/20 0.44
ALOX15 P16050 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27807655 0.88 CACNA1G (0.45) SMN1; SMN2CACNA1GCACNA1HCACNA1INPC1
SCHEMBL26202213 0.86 CACNA1G (0.54) SMN1; SMN2CACNA1GCACNA1HCACNA1INPC1
SCHEMBL4288842 0.84 HDAC1 (0.56) SMN1; SMN2CACNA1GCACNA1HCACNA1INPC1
SCHEMBL31220195 0.84 CACNA1G (0.53) CACNA1GCACNA1HCACNA1INPC1RAB9A
SCHEMBL4672568 0.77 CACNA1G (0.47) SMN1; SMN2CACNA1GCACNA1HCACNA1INPC1
SCHEMBL27785815 0.77 CACNA1G (0.47) SMN1; SMN2CACNA1GCACNA1HCACNA1INPC1
SCHEMBL15964859 0.77 SCD (0.59) SMN1; SMN2NPC1RAB9AHDAC1LMNA
SCHEMBL4324414 0.76 ALDH1A1 (0.54) SMN1; SMN2NPC1RAB9ATSHRLMNA
SCHEMBL28136392 0.76 KMT2A (0.51) SMN1; SMN2CACNA1GCACNA1HCACNA1INPC1
SCHEMBL2823500 0.76 TDP1 (0.43) SMN1; SMN2NPC1RAB9ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106573006-A Heterocyclic amides of RIP1 kinase inhibitors as pharmaceuticals 葛兰素史密斯克莱知识产权发展有限公司 2017-04-19 CN disclosed
WO-2008027442-A2 ABUSE DETERRENT ORAL PHARMACEUTICAL FORMULATIONS OF OPIOID AGONISTS AND METHOD OF USE THERAQUEST BIOSCIENCES, LLC (US) 2008-03-06 WO disclosed